EIGR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: EIGR Shares Outstanding History and EIGR YTD Return |
EIGR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: EIGR Shares Outstanding History and EIGR YTD Return |
EIGR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-22.26% CAGR Mouse over chart for data details
|
EIGR Stock Price Chart |
About Eiger BioPharmaceuticals Inc |
Eiger BioPharmaceuticals is a commercial-stage biopharmaceutical company. Co.'s portfolio includes a late-stage clinical development pipeline with five clinical product candidates and one U.S. Food and Drug Administration (FDA)-approved product. Co.'s clinical product candidates include: Lonafarnib for Hepatitis Delta Virus (HDV), Peginterferon Lambda for HDV, Combination Therapy for HDV; Peginterferon Lambda (lambda) for COVID-19, Avexitide in Congenital Hyperinsulinism, and Avexitide in Post-Bariatric Hypoglycemia. Co. has received FDA approval for Zokinvy to reduce the risk of mortality in Progeria and to treat processing-deficient Progeroid Laminopathies. We show 33 historical shares outstanding datapoints in our EIGR shares outstanding history coverage, used to compute EIGR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EIGR market cap history over the course of time is important for investors interested in comparing EIGR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EIGR versus a peer is one thing; comparing EIGR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EIGR can fluctuate over the course of history. With this page we aim to empower investors researching EIGR by allowing them to research the EIGR market cap history. |
EIGR Current Stock Quote |
Free EIGR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
EIGR Share Performance |
Market Cap Peers |
Eiger BioPharmaceuticals (EIGR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
EKSO Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.